Table 3. Univariate and multivariate analysis of factors associated with overall survival in patients receiving SIRT.
Variable | Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | ||
ECOG [0 & 1] | 0.022 | 0.003-0.185 | 0.0005 | 0.039 | 0.004-0.352 | 0.0039 | |
ECOG [2] | 0.028 | 0.003-0.273 | 0.0021 | 0.064 | 0.0006-0.696 | 0.0239 | |
Pre-treatment platelet | 0.999 | 0.996-1.001 | 0.309 | ||||
Post-treatment platelet | 1 | 0.998-1.002 | 0.7323 | ||||
Pre-neutrophil | 1.059 | 0.961-1.166 | 0.2499 | ||||
Post-neutrophil | 1.151 | 1.071-1.238 | 0.0001 | ||||
Pre-lymphocyte | 0.831 | 0.596-1.159 | 0.2753 | ||||
Post-lymphocyte | 0.617 | 0.274-1.339 | 0.2437 | ||||
Pre NLR | 1.049 | 0.974-1.13 | 0.2075 | ||||
Post NLR | 1.014 | 1.005-1.024 | 0.0041 | 1.016 | 0.999-1.034 | 0.0662 | |
ΔNLR | 0.997 | 0.983-1.012 | 0.6836 | ||||
Pre PLR | 1.001 | 0.999-1.002 | 0.2624 | 1.003 | 1-1.005 | 0.0183 | |
Post PLR | 1.001 | 1-1.001 | 0.0422 | ||||
ΔPLR | 1.111 | 0.993-1.243 | 0.066 | 1.285 | 1.037-1.592 | 0.0219 | |
Liver tumor volume | 1.01 | 1.001-1.002 | 0.0005 | 1.001 | 1-1.002 | 0.0086 | |
Liver tumor burden % | 1.016 | 1.005-1.026 | 0.0042 |
SIRT, selective internal radiation therapy; ECOG, Eastern Cooperative Oncology Group; NLR, neutrophil-to-lymphocyte; PLR, platelet-to-lymphocyte ratios.